Compare Dolby Laboratories, Inc. (DLB) vs Heron Therapeutics Inc (HRTX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Dolby Laboratories, Inc. vs Heron Therapeutics Inc — how do they compare? Dolby Laboratories, Inc. trades at $48.49 (market cap $4.59B), while Heron Therapeutics Inc trades at $0.46 (market cap $82.52M). The key difference: Dolby Laboratories, Inc. is far larger — about 55.6× Heron Therapeutics Inc's market cap, and Dolby Laboratories, Inc. pays a 2.91% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals.
| DLB | HRTX | |
|---|---|---|
Market Cap | $4.59B | $82.52M |
Sector | Industrials | Health |
52-Week High | $76.79 | $2.04 |
52-Week Low | $48.51 | $0.39 |
Enterprise Value | $4.04B | $180.42M |
Dividend Yield | 2.91% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Dolby Laboratories (DLB) trades at $49.36, down 0.88% on the day, with a bearish technical outlook. The company maintains strong fundamentals, including a P/E of 19.59, a net income margin of 17.85%, and consistent earnings beats in recent quarters. Recent news highlights include its role in powering immersive audio for the FIFA World Cup 2026 coverage and recognition as a top supplier by General Motors.
The stock presents a value opportunity given its discount to the analyst consensus price target of $87.50, but faces near-term headwinds from bearish technical signals and cyclical end-market exposure. Upside potential hinges on continued licensing growth and execution, while risks include market sentiment and competitive pressures.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Dolby Laboratories, Inc.
Dolby Laboratories Inc develops audio and surround sound for cinema, broadcast, home audio systems, in-car entertainment systems, DVD players, games, televisions, and personal computers. The company generates three fourths of its revenue from licensing its technology to consumer electronics manufacturers around the world. The rest of revenue comes from equipment sales to professional producers and audio engineering services.
Read more on DLB →About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →
